We understand that every scientific advancement counts when it comes to bringing new medicines to those in need.
At Pfizer our biotechnology is our foundation. With 25,000 clinical researchers testing everyday, pharmaceutical development and innovation are our focus.
Uncovering New Therapies
We understand that every scientific advancement counts when it comes to bringing new medicines to those in need. Of the 7,000 known rare diseases, less than 5% have an approved treatment option. This gap in care has spurred a sense of urgency—to find new, potentially life-changing approaches today.
Our Medicines In Development
Our priority is researching and developing medicines and vaccines that will benefit patients around the world. We are committed to addressing unmet needs across a number of important therapeutic areas including, Oncology, Inflammation & Immunology, Vaccines, Internal Medicine and Rare Disease, with the goal of delivering innovative products to patients.